Drugs / TIVc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01857206 | May 2013 → Jun 2014 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIVc | “This study compared the safety and tolerability of TIVc with an egg-derived trivalent influenza vaccine (TIVf) in 4-17 yearolds.” PMID 26643931 ↗ Nov 2015 |
| Modality | Vaccine | “Cell culture-derived inactivated influenza vaccines (TIVc) are necessary for scale and predictability of production to meet global demand.” PMID 26643931 ↗ Nov 2015 |